NICE Newsletter

NICE is an independent organisation responsible for providing national guidance on promoting good health and preventing and treating ill health.
Updated: 21 hours 17 min ago
Health Act makes NICE stronger than ever before
Health Act makes NICE stronger than ever before
Revised patient access scheme and more information allow NICE to recommend abiraterone for prostate cancer
NICE, the healthcare guidance body, has issued new draft guidance recommending the use of abiraterone (Zytiga, Janssen) in combination with prednisone or prednisolone for the treatment of castration-resistant metastatic prostate cancer that has progressed after one docetaxel-containing therapy
Shared Learning Awards 2012 winner announced
Shared Learning Awards 2012 winner announced
Integration 'key' to managing public health transition
Integration 'key' to managing public health transition
NICE should produce guidance on multiple morbidities
NICE should produce guidance on multiple morbidities
NHS Commissioning Board to embrace NICE
NHS Commissioning Board to embrace NICE
